mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-14 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |